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Fifty-one schizophrenic patients were randomly assigned to receive insight-oriented or
supportive psychotherapy. After two years of treatment, their outcomes were compared on a
broad range of measures. The results ofthe two therapies were, for the most part, similar. Some
advantages for each were also seen in the sectors of outcome toward which the two treatments
were focused. The supportive therapy group did better in areas of practical adaptation and the
insight therapy group did better in areas ofintrapsychic function.
The practice of psychotherapy with schizophrenic patients was given major impor-
tance through the optimistic endorsements provided by Harry Stack Sullivan and his
students. These spokespeople were enormously influential in drawing attention to both
the pathogenic and therapeutic possibilities of psychosocial factors on schizophrenic
individuals. They openly challenged the beliefthatschizophrenia was a largelyorganic
disorder predictive of a downhill course. In its place, they advocated a model for
schizophrenia in which the illness was seen as essentially a problem in relating to other
people, which could be altered by a corrective relationship with a trained therapeutic
person. In a larger sense, the humanistic message and hopeful possibility that curative
change could be achieved for schizophrenic patients captured the attention of the
entire mental health field.
To evaluate this possibility, five studies were done in the 1960s by Fairweather et al.
[1], Rogers et al. [2], Grinspoon et al. [3], Karon and VandenBos [4], and May [5].
Because these studies overall failed to confirm the powerful benefits for psychotherapy
which were hoped for, their effect was to raise serious doubts about its value. Despite
the resulting decline in enthusiasm within academic psychiatry for the therapy of
schizophrenia, these studies had little impact on the practices of those who had been
advocating and providing this service. For them, the limitations of the studies
precluded any serious judgment about the value of the work as it was practiced.
Thoughtful proponents of psychotherapy for schizophrenic patients felt that the
studies failed to utilize therapists who weresufficiently skilled, failed to follow patients
for long enough periods of time to find differences, and failed to utilize samples of
patients on whom good results could be expected. Finally, they argued that the nature
ofthe changes caused by psychotherapy-when well conducted on suitable patients-
was not likely to be tapped by the outcome measures of recidivism and role
performance that typically were used.
The Clinical Research Branch of the National Institute of Mental Health recog-
nized the danger ofa premature closure to this ongoing and reasonable controversy. In
373
Copyright e 1985 by The Yale Journal ofBiology and Medicine, Inc.
All rights ofreproduction in any form reserved.GUNDERSON AND FRANK
fact, thedivergent results obtained by Karon and VandenBos [4] and May [5] and the
divergent interpretations by empiricists and clinicians seemed to indicate that these
prior studies had aggravated rather than resolved this controversy. There existed a
clear possibility of foreclosing a treatment which might offer the best hope for truly
deep and enduring change in schizophrenic psychopathology. This possibility was
recognized even by those whose criticisms of psychotherapy's effectiveness had been
vindicatedby itsdisappointing performance in these studies. Thus, the ongoing debates
about its effectiveness and the obvious importance of the issue made further and more
definitive studies of this problem highly desirable.
In this context, the National Institute of Mental Health sought to involve experi-
enced therapists in the research through a series of workshops organized by Loren
Mosher andmyselffrom 1971 to 1975. Eventually, thisgaveway to the development of
the current project under the direction of the late Alfred H. Stanton along with Peter
Knapp and myself. This paper gives a condensed description of the design and main
effect analysis from this project. The design of this project attempted to utilize what
had been learned fromprior studies and then toimprove upon them when possible. We
set out to compare the forms ofpsychotherapy which represented the two most usual
forms of individual psychotherapy currently practiced. One, entitled "Exploratory
Insight Oriented" psychotherapy, hereafter referred to as EIO, was to be contrasted
with"RealityAdaptiveSupportive" psychotherapy, hereafter referred to as RAS. The
EIO therapy was to be provided three times weekly and the RAS therapy was to be
once weekly.
Ourdesign called for amid-rangeprognosticgroupofschizophrenic patients so as to
rule out thevery chronic and thevery acute. Despite changes in diagnostic standards,
allpatients met research criteria forschizophrenia and most fulfilled the narrow DSM
III criteria at time of admission. To be in the study, patients were required to have
completed over six months within their assigned form of therapy. As shown in Fig. 1,
95 patients formed our study sample; ultimately we had 51 who remained in their
assigned treatment (28 RAS and 23 EIO) for the two-year study period.
All patients wereinitially hospitalized and, in addition to their assigned psychother-
apy, received active milieu treatment, flexible but expertly guided pharmacotherapy,
and the usual range of aftercare services-halfway houses, home, day care, and the
like.
Thetherapists in thisstudywereselected for their experience (both groups averaged
about ten years) and commitment to both the treatment of schizophrenia and the
particular model of treatment which they purveyed. They were fully reimbursed for
their services. As reported earlier by Frosch et al. [6], the RAS therapists basically
adopted the view ofschizophrenia as biological, emphasized medications, and focused
on the practical issues of daily life. In contrast, the EIO therapists were mainly
analysts, were more non-directive, and believed schizophrenia had important develop-
mental determinants. They focused more on thetherapeutic relationship and the past.
Areas in which we expected the supportive therapy to differ from the insight-
oriented therapy are summarized in Table 1. The following clinical example helps to
illustrate these differences further by showing how these two approaches were
expected to contrast. In this example, a patient reports to his therapist that he had
attended a party, but he had left early and gone home because he felt upset.
RAS The RAS therapist would attempt. to identify the consequences of this
behavior. "Ifyou leavesuchparties,youwillnotbeabletomakefriends. This will only
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add to your sense ofloneliness." He will help the patient anticipate future situations in
wbich such reactions might recur. "The next time you go to a party, we should discuss
this because you can expect tofeelsimilarly upset." He will feel free tosuggest that the
patient's reasons for being upset are unrealistic and that the fearful consequences he
expected from staying at the party are symptoms of his illness. As a result, the RAS
therapist might then direct the patient not to act on this feeling, but to stay at the next
party with the added encouragement that he believes the patient is able to do this and
will be better offifhe does.
EIO The EIO therapist would be likely to inquire in more detail about what was
going on at the party-the intent being to isolate the precipitant and focus on the
interpersonal context in which the patient's maladaptive behavior began, i.e., his
withdrawal. Second, the EIO therapist would try to understand more about the nature
of the patient's being upset: What were the physical sensations? Had the patient felt
that way before? When? Where? In this way, the therapist would try to anchor the
experience both within the patient's body, thereby helping to establish ownership and
identity, but also to anchor it in terms ofthe patient's ongoing life experience so that
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TABLE I
Description of the Therapies
RAS
1. Objectives
2. Interview focus
3. Psychic arena
4. Temporal focus
5. Techniques
6. Transference
7. Countertransference
Symptom reliefvia drug management
and strengthening ofexisting de-
fenses
Management, complaints, interper-
sonal problems, current situational
problems
Focus on what is already aware, no
hidden agendas
Present and future
Support, reassurance, limits, clarifica-
tion, direction, suggestions for envi-
ronmental manipulation, use of com-
munity resources
Encourage positive to further alliance,
actively discourage negative
Positive feelings important and ex-
pressable, control negative
Self-understanding: how one feels and
thinks and how these influence the
course ofone's life
Relationship to therapist and signifi-
cant others, exploration offeelings
and conflicts
Look for current meanings, hidden mo-
tivation, unconscious
Present and past
Support, reassurance, limits, clarifica-
tion, interpretation, catharsis
Accept positive and work through neg-
ative
Mixed feelings expected and generally
not disclosed
some perspective on this feeling state and the patient's flight from it could be attained.
Possibly, the nature of the feared consequence would be explored, i.e., the fantasies
which mobilized the retreat from the party, "What do you imagine would have
happened?" and so on. Finally, the therapist would be aware ofand potentially would
explore the transference meaning ofthe patient's reporting this incident. For example,
"Had you hoped I might be able to help you in some way with this?"
We examined the degree to which the two therapies differed in ways called for by
our design and as illustrated in Table 1 and this clinical vignette. To do this, we
examined reports from both patient and therapist which were obtained on a monthly
basis, as well as from tapes which were recorded whenever possible. Our initial
impressions are that in termsofobjectives the two therapies clearly differed in the ways
described. Also, with respect to interview focus, there were cleardifferences, especially
in the degree to which the RAS therapists focused more on drug management and the
EIO therapists more on exploring conflict. Differences in the psychic arena that were
prescribed were harder to assess. Our ratings indicated much more attention by ErO
therapists to thoughts and memories, to undercurrents, and even to unconscious issues.
As desired by our design, both types of therapy paid attention to the present and the
EIO type attended more to the past. In the area of techniques, there was more
crossover than had been planned in the design. Namely, the RAS and EIO therapists
both provided similar and high levels of support in the form of suggestions, reality
testing, encouragement, and warmth. In the areas oftransference and countertransfer-
ence, we were not satisfied fully with our ability to assess the expected differences, but
the differences which were found were all in the directions predicted; namely, EIO
therapists were more interested in working with negative feelings and clearly focused
more on the within-session relationship to the therapist.
Before leaving the subject of the study's design, I would like to comment on the
depth and the breadth of the assessments which were done on study patients. Quite
aside from the assessments which were done on the therapists and on the therapies
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themselves, there were extensive evaluations done on all major areas of outcome,
including those which might be specific to schizophrenics in intensive psychotherapy
and involving areas which had generally received little attention in prior research,
namely, intrapsychic, ego-functioning, interpersonal, and cognitive areas of outcome.
In all, patients were seen every six months and received over six hours ofassessment at
baseline and every six months thereafter for follow-up visits.
RESULTS
Engagement/Continuance
Figure 1 illustrates that we had considerable attrition in our sample over the
two-year study period. Ofthe 164 patients found suitable forthisstudy, 95 remained in
their assigned treatment beyond the first six months and only about halfofthese were
still in their assigned treatment at two years. Katz et al. [7] have reported that our
dropouts most usually left treatment because ofresistance on the part ofthe family or
the patient and only rarely outofthe logistical problemsofrelocation or finances. Most
of the patients who did drop out went on to receive a good deal of treatment over the
next two years. Unfortunately, we were not able to get comparable outcome informa-
tion on this group as compared to the 95 study patients who remained beyond six
months.
The frequency with which patients dropped out highlights an important clinical
problem associated with individual psychotherapy or other psychosocial therapies with
schizophrenicpatients. Wefound that thepatients whoremained in supportivetherapy
were systematically different from those who remained in the insight-oriented modal-
ity [8,9]. Patients who have positive symptoms of schizophrenia such as manifest
cognitive and behavioral disturbance, but who are relatively optimistic about their
prospect ofrecovery, are more likely to be engaged and remain in supportive therapy.
This makes sense because the supportive (RAS) therapy is a focused treatment which
reinforces a patient's expectations of a good response and because patients with
positive symptoms welcome a treatment that is not tooemotionally and interpersonally
demanding. By contrast, the type ofpatient who is more likely to become engaged and
remain in insight-oriented (EIO) therapy is the patient who has negative symptoms,
such as social isolation and retardation apathy, and who has more modest expectations
regarding future prospects. EIO remainers also have more education. The type of
treatment an EIO therapist offers makes sense for a patient who has been worn down
by the illness or previous exposures totreatment, but who hastherequisitecompulsitiv-
ity to attend intensive therapy on a regular basis. Insight-oriented therapists tend to
emphasize the serious prognostic implications ofschizophrenia, the need for long-term
treatment, and the need to search out covert causes. They offer the hope that a slower,
more basic change can be hoped for. This approach makes sense for patients who have
some stable but unsatisfactory level of function and who view their illness discour-
agingly.
These differences in the types of patients who remain in the insight-oriented and
supportive therapies have implications for matching types of individual therapy with
different subgroups ofschizophrenic patients. Regardless ofwhat type oftherapy our
study patients received, it was clearly not the stereotypic, good psychotherapy patient
(i.e., acute, intelligent, insightful, and affectively available) who was most apt to
remain in treatment.
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Outcome
The high frequency ofdropouts also had implications for the assessment ofoutcome.
The sample remaining in treatment for two years was no longer representative of the
general population of patients beginning treatment and, in fact, was systematically
different in some ways. In order to deal with this problem, we supplemented usual
group contrast techniques with partial correlations and we relied heavily upon effect
size analyses. A full description of these techniques and their rationale is available to
the interested reader elsewhere [10].
We hypothesized that the patients who received the exploratory insight-oriented
psychotherapy (EIO) would show greater improvement than patients receiving reality
adaptive supportive psychotherapy (RAS) after two years in the seven areas listed.
(These hypotheses are listed in order of the size of the expected between-group
differences that we predicted.)
1. Cognition: Patients given EIO treatment would show more clarity, precision,
accuracy ofthought, and less confusion than patients given RAS treatment.
2. Ego Functioning: The capacity to delay, understand, modulate, and express
impulses and emotions as well as flexibility and ease in communicating would be
greater in the EIO group than in the RAS group.
3. Interpersonal Relationships: The ability to form and maintain reliable, dura-
ble, satisfying, and mature relationships would be greater for patients given EIO than
RAS treatment.
4. Signs and Symptoms: Manifest disturbances ofideation or affect would be less
in the EIO than in the RAS group.
5. Major Role Performance: EIO patients would do better in both family and
work roles than RAS patients. More particularly, EIO patients would assume higher
occupational levels than RAS patients after the first year oftreatment.
6. Medication: The EIO patients would require less medication than RAS
patients after the first year oftreatment.
7. Hospitalization: Initially, time spent in the hospital would be greater in the
EIO group than in the RAS group. Over time, however, EIO patients would require
progressively less hospital treatment so that by two years the situation would be
reversed, and total time spent in the hospital would be greater for RAS than EIO
patients.
Because we expected that these hypothesized differences would be most pronounced
for those patients who received the maximum dose oftreatment, i.e., who remained in
their assigned therapy condition for the full two years of the study, and so as not to
confound the results by variations in amounts of treatment received, only the 51
therapy remainers are used in analyses reported here and summarized in Table 2.
1. Cognitive Functioning: Included in this domain were measures of (a) thought
disorganization and (b) clarity and depth of insight. Contrary to what was hypothe-
sized, EIO and RAS patients showed comparable increases in their capacity to reflect
on their experiences and realistically appraise their difficulties (i.e., in insight)
between baseline and the two-year follow-up. Likewise, in the area of thought
disorganization, the two groups did not significantly differ, although a trend favoring
the EIO treatment was apparent from the effect size calculations. In summary, there
was some evidence supporting the hypothesis that EIO treatment exercised preferen-
tial effects in the area of cognitive functioning. Nevertheless, the effects were small,
and for the most part confined to a reduction in thought disorganization. Overall, these
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TABLE 2
Summary of Results of Hypothesis Testing Based on Group
Contrasts at 24 Months with Remainers Only
Results Favor
EIO RAS Neither
Cognitive functioning
Thought disorganization x
Insight x
Ego functioning x
Interpersonal relationships x
Signs and symptoms x
Major role performance
Social functioning x
Self-sufficiency x
Occupational functioning x
Medications x
Hospitalization x
analyses failed to confirm the strong effects expected in this outcome domain for the
EIO treatment.
2. Ego Functioning: A moderately sized effect favoring the EIO treatment was
found. Thus, the hypothesis that, over time, EIO patients would become more able to
delay, understand, modulate, and express impulses and emotions than RAS patients
received some support.
3. Interpersonal Relationships: No differences between EIO and RAS patients in
their capacity to form and maintain meaningful relationships were found. In both
groups, only a minority of the patients (approximately one-third) were able to form
such relationships during the two-year follow-up period.
4. Signs and Symptoms: Again, contrary to what had been hypothesized, EIO
and RAS patients showed comparable reductions in symptomatology between baseline
and the two-year follow-up.
5. Major Role Performance: The hypothesis about the differential effects of the
EIO and RAS treatments in this area needs to be examined in more detail since the
domain includes measures in three different areas: (a) Occupational functioning-
Analysis of occupational functioning clearly refuted the hypothesis that EIO patients
would outperform RAS patients over the course oftwo years. Theadv,4ntage found for
the RAS group in occupational functioning was clear, substantial, and significant. (b)
Self-sufficiency-In the area of self-sufficiency, the better performance of the RAS
patients seen in the area of occupational functioning Was only weakly mirrored. This
aspect ofrole performance was assessed by examining the number ofdays the patients
spent functioning independently and the degree to which they were able to support
themselves financially, without assistance from family or significant others. Since EIO
patients spent far more time in the hospital (which was considered time as a
dependent) than RAS patients, their similar level of self-sufficiency indicates that
when they (i.e., EIO patients) were out of the hospital, they achieved a fair degree of
independence. (c) Social functioning-EIO patients also made a social adaptation that
was comparable to the RAS patients. There was, however, a weak but noticeable trend
favoring patients in the RAS condition.
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In sum, by various measures of role performance, but especially according to the
measure of occupational functioning, differences were found which spoke to the
preferential benefits of the RAS treatment, and which ran counter to our hypotheses.
6. Medications: Both groups received considerable pharmacotherapy throughout
the study period but did not differ in terms of amount of usage. There was no tendency
for patients in EIO to receive less medication over time than RAS patients.
7. Hospitalization: As noted, EIO patients spent considerably more time in the
hospital than RAS patients in the two-year study period, despite the fact that RAS
patients were rehospitalized somewhat more often. This difference in the total number
of days spent in the hospital was largely accounted for by the longer initial
hospitalization of the EIO patients. While the observed difference in length of initial
hospitalization was consistent with what had been predicted, the observed difference in
overall amount of time spent hospitalized was not. Specifically, the hypothesis that
over time EIO patients would require progressively less hospital treatment compared to
RAS patients was not confirmed.
Two obvious questions are whether these results would have been different if the size
of the sample were larger or if the length of therapy had been longer. With regard to
the first issue, I think a larger sample would probably not affect the results. Our results
were generally consistent with prior work-thereby adding consensual validity to each
other. Moreover, our interpretation of the results depended on effect size, i.e.,
magnitude of differences rather more than statistical significance. With regard to the
second question, it remains a possibility that a longer duration of psychotherapy might
increase the differences. However, even if this occurred, the failure to show differences
in two years would speak to a significant limitation in EIO, and our present analyses
showed that the magnitude of group differences leveled off after 12 months. They were
not present at six months but remained about the same from 12 months to 24 months.
Future analyses will look closely at the subsequent course for the 30 patients who
remained three years or more as well as whether other statistical techniques would
yield different results.
Subgroup Analyses
Another question raised by this study is whether there are characteristics of the
patients or within the psychotherapy itself (i.e., process variables) which predict good
or poor response to either EIO or RAS therapy. Our results to date indicate that the
overall ability of baseline patient characteristics to predict outcome was weak. There
was a preliminary result that the presumably "good" therapy patients (i.e., bright,
acutely disturbed, young) did, as expected, well in RAS; but, contrary to predictions,
did poorly in EIO. Within the EIO treatment, agitation and hostility at baseline was a
useful discriminator of subsequent outcome. Patients in EIO who were initially hostile
and agitated tended to do well. Patients in EIO who were less hostile and agitated, but
were more anxious or depressed initially, did poorly.
Other analyses suggest that what went on in the therapy itself was a stronger
predictor of outcome than were patient characteristics. More will be said about this
important area, but further dissection of the data and clinical synthesis by us is still
needed.
DISCUSSION
A picture emerges from this study of a complex interaction between the type of
psychotherapy which is provided and the domain of psychopathology which is affected.
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The results cannot be reduced to a single statement that one form of therapy is
preferable to the other. Indeed, patients in both RAS and EIO improved considerably
in almost every area ofoutcome. Still, the results failed to confirm either the strength
or the breadth of favorable effects that we hypothesized would be associated with the
EIO as opposed to the RAS treatment. Instead, the data suggest that in the areas of
recidivism and role performance (i.e., occupational functioning, hospitalization, and to
a lesser extent social adaptation), RAS therapy exerts preferential and specific action
compared with EIO therapy. In contrast, EIO therapy appears to exert preferential
albeit more modest action in the areas ofego functioning and cognition (i.e., adaptive
regression and to a lesser extent thought disorganization). These results are generally
consistent with the focus and intention of the two treatment modalities. That is, the
EIO therapy was directed more toward reducing disturbances in interpretation of
events and toward promoting self-knowledge and understanding, while the RAS
therapy was more concerned with the practical issues of daily living. Although each
treatment exerted preferential action in the sectors toward which its attention was
directed, neither EIO nor RAS had an apparent advantage overtheother in theimpact
on most aspects ofthe schizophrenic patient's psychopathology.
Future analyses are under way to explore whether greater duration of treatment
would affect these conclusions and, more important, whether there were subgroups of
good responders who can be identified on the basis ofeither their baseline characteris-
tics or the nature ofthe psychotherapeutic processes.
REFERENCES
1. Fairweather GW, Simon R, Gebbard ME, Weingarten E, Holland JL, Sanders R, Stone GB, Reahl JE:
Relative Effectiveness of Psychotherapeutic Programs: A Multi-Criterial Comparison of Four
Programs for Three Different Patient Groups. Psychol Monogr 74 (492):1-26, 1960
2. Rogers CR, Gendlin EG, Kiesler DJ, Truax CB (ed): The Therapeutic Relationship and Its Impact:
Study ofPsychotherapy With Schizophrenics. Madison, The University ofWisconsin Press, 1967
3. Grinspoon L, Ewalt JR, Shader R: Long-Term Treatment of Chronic Schizophrenia. A Preliminary
Report. Int J Psychiat 4:116-128, 1967
4. Karon BP, VandenBos GR: Psychotherapy of Schizophrenia: The Treatment of Choice. New York,
Jason Aronson, 1981
5. May PRA: Treatment ofSchizophrenia: A ComparativeStudyofFive Treatment Methods. New York,
Science House, 1968
6. Frosch JP, Gunderson JG, Stanton AH: Therapists Who Treat Schizophrenic Patients: Characteriza-
tions. Presented at the 136th Annual MeetingoftheAmerican PsychiatricAssociation, New York, May
6, 1983
7. Katz HM, Frank A, Gunderson JG, Hamm D: Psychotherapy of Schizophrenia: What Happens to
Treatment Dropouts. Journal ofNervous and Mental Disease 172 (6):326-333, 1984
8. Gunderson JG: Engagement of Schizophrenic Patients in Psychotherapy. In Attachment and the
Evolution of A Self. Edited by Y Akabane, JL Sacksteder, DP Schwartz. New York, International
Universities Press, in press
9. Frank AF, Gunderson JG, Gomes-Schwartz B: Engagement ofSchizophrenic Patients in Psychothera-
py: Patient and Therapist Predictors. Unpublished manuscript
10. Gunderson JG, FrankAF, Katz HM, Vannicell ML, Frosch JP, Knapp PH: EffectsofPsychotherapy in
Schizophrenia: II. Comparative Outcome of Two Forms of Treatment. Schizophrenia Bulletin 10
(4):564-598, 1984